Drug intelligence / Profile preview

Fuzheng Jiedu Decoction

Development stage: Unknown
Lead developer: Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Administration: Oral

Overview

Fuzheng Jiedu Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by researchers at Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine. It is primarily investigated for the treatment of immune thrombocytopenia (ITP), particularly in pediatric populations. The decoction is designed based on TCM principles of Fuzheng (strengthening the body's resistance) and Jiedu (detoxifying/clearing heat). In the context of ITP, it is studied for its potential to improve platelet function and regulate the immune system, though its specific molecular targets are often multi-factorial and characteristic of complex herbal mixtures.

Other names: Fuzheng Jiedu Tang扶正解毒汤

Beyond the preview

Go deeper on Fuzheng Jiedu Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fuzheng Jiedu Decoction.

Explore the full profile